Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
Crossref DOI link: https://doi.org/10.1007/s40801-015-0043-4
Published Online: 2015-10-13
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pesa, Jacqueline A.
Muser, Erik
Montejano, Leslie B.
Smith, David M.
Meyers, Oren I.
Funding for this research was provided by:
Janssen Scientific Affairs, LLC.
License valid from 2015-10-13